摘要
目的三阴性乳腺癌(TNBC)具有侵袭性强、缺乏有效的治疗方案、预后差的特殊生物学和临床病理学特征。目前磁共振成像是诊断TNBC最准确的影像学检查方法,可协助诊断和预后评估。乳腺癌新辅助化疗(NAC)已逐渐形成规范化的治疗,是乳腺癌综合治疗的重要组成部分,因此评价新辅助化疗疗效的方法成为临床医生所共同关注的焦点。本文对磁共振评价三阴性乳腺癌新辅助化疗疗效的现状及进展做一综述。
Triple-negative breast cancer （TNBC）, which is characterized by distinct biological and clinical pathological fea- tures, has a worse prognosis because of the lack of effective therapy. Breast MRI is the most accurate imaging modality for diagno- sis of TNBC currently. Neoadjuvant chemotherapy （ NAC ） has gradually been the normalization therapy, which is an important part of combined therapy for breast cancer. So the evaluation of the efficacy of neoadjuvant chemotherapy methods becomes the common focus of clinicians. This article has reviewed the present situation and progress of curative effect of neoadjuvant chemo- therapy in triple-negative breast cancer by imaging.
出处
《医学影像学杂志》
2017年第1期158-161,共4页
Journal of Medical Imaging
关键词
三阴性乳腺癌
磁共振成像
新辅助化疗
Triple negative breast cancer
Magnetic resonance imaging
Neoadjuvant chemotherapy
